Trump 2.0: Making America Healthy Again?

President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. (often referred to as RFK) to head up the US Department of Health and Human Services – which also includes the Centres for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Food and Drug Administration (FDA) – has certainly raised some eyebrows and the Senate confirmation process may face hurdles. However, whatever the outcome of his confirmation – or otherwise – this development is already causing some volatility in the healthcare space, and this is likely to continue into the new year.